Biotricity, Inc. BTCY

Company Overview

Biotricity, Inc. (NASDAQ: BTCY) is a medical technology and remote patient monitoring company focused on cardiovascular diagnostics, chronic care management, and connected healthcare solutions. The company operates within the digital health, cardiac monitoring, and medical device industries, developing FDA-cleared technologies that enable physicians to remotely monitor patients with cardiac and other chronic conditions. Its business model combines proprietary hardware, cloud-based software, analytics, and recurring monitoring services intended to support early diagnosis and long-term patient management.

The company’s primary revenue drivers include its remote cardiac monitoring ecosystem, diagnostic services, and subscription-based monitoring platforms. Key products include Bioflux, a mobile cardiac telemetry solution; Biotres, a three-channel wearable cardiac monitoring device; and Biocare Cardiac, a clinical monitoring platform. Biotricity primarily serves physicians, cardiology practices, diagnostic testing providers, healthcare systems, and ambulatory monitoring markets in the United States. The company was founded in 2012 and evolved from a consumer-focused biometric concept into a clinically oriented cardiac diagnostics and remote healthcare platform emphasizing continuous monitoring, data integration, and preventative care.